The recommendations follow the World Health Organization’s recent update to its classifications of central nervous system (CNS) tumors to now include a structure for pediatric patients with CNS tumors ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted accelerated approval to entrectinib for infants aged 1 month and older who have solid tumors ...

In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts caution that more research is needed. Gavin Nielsen was 2 years old when he ...

Sequencing circulating tumor cell-free DNA (cfDNA) in cerebrospinal fluid (CSF) improved diagnosis, decision-making, and clinical care in pediatric and adolescent and young adult (AYA) patients with ...

Pediatric non-small cell lung cancer (NSCLC) is a type of lung cancer that affects children and adolescents. It may be treatable using methods such as surgery and chemotherapy. Pediatric NSCLC is the ...

Please provide your email address to receive an email when new articles are posted on . Genomic sequencing of tumors enabled 107 patients with pediatric cancer who ...

Today, the National Comprehensive Cancer Network ® (NCCN ®) published new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) for Pediatric Central Nervous System (CNS) Cancers. This is ...

Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial ...